Clinical Trial Update: A Clinical Study on Levosimendan Improvement of Prognosis of ARDS Patients by Optimizing Pulmonary Hemodynamics [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating levosimendan for improving prognosis in ARDS by optimizing pulmonary hemodynamics is underway, status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Shenzhen Second People's Hospital | Conditions: ARDS, Human | Phase 3 | Status: UNKNOWN